Irish Takeover Pane Rule 38.5

RNS Number:4096M
Investec Bank (UK) Limited
23 January 2008




                   DEALINGS BY CONNECTED EXEMPT MARKET MAKERS
                    (Rule 38.5 of the Irish Takeover Panel)


1.         KEY INFORMATION

Name of exempt market maker                    INVESTEC BANK (UK)  LTD

Company dealt in                               ALLTRACEL PHARMACEUTICAL PLC

Class of relevant security to which the        ORDINARY SHARES
dealings being disclosed relate (Note 1)

Date of dealing                                22/01/2008



2.         DEALINGS (Note 2)

(a)        Purchases and sales

Total number of securities purchased   Highest price paid (Note 3)           Lowest price paid (Note 3)





Total number of securities sold        Highest price received (Note 3)       Lowest price received (Note 3)

50,000                                 10.5p                                 10.5p




(b)        Derivatives transactions (other than options)

Product name,         Long/short (Note 4)       Number of securities (Note 5)        Price per unit (Note 3)
e.g. CFD





(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying


Product name,         Writing, selling, Number of securities  Exercise   Type, e.g.      Expiry     Option money
                      purchasing,       to which the option              American,
e.g. call option      varying etc.      relates (Note 5)      price      European etc.   date       paid/received per
                                                                                                    unit (Note 3)





(ii)        Exercising

Product name, e.g. call option         Number of securities                  Exercise price per unit (Note 3)






3.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating
to the voting rights of any relevant securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is
referenced.  If none, this should be stated.



Date of disclosure                                                23/01/2008

Contact name                                                      DAVID BURFOOT

Telephone number                                                  020 7597 4394

Name of offeree/offeror with which connected                      ALLTRACEL PHARMACEUTICALS PLC

Nature of connection (Note 6)                                     BROKER






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

EMMMGGZMVFDGRZM